Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Barbaloin, (s)-isomer
2. Barbaloin, Beta-d-isomer
3. Barbaloin, Monoglucoside
4. Isobarbaloin
1. Aloin
2. 1415-73-2
3. Aloin A
4. Barbaloin A
5. Aloinum
6. Chebi:2991
7. Mfcd00151160
8. 1,8-dihydroxy-3-hydroxymethyl-10-(6-hydroxymethyl-3,4,5-trihydroxy-2-pyranyl)anthrone
9. Aloin [ban]
10. 648rw354s9
11. Dsstox_cid_25967
12. (10s)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10h-anthracen-9-one
13. (1s)-1,5-anhydro-1-[(9s)-4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9,10-dihydroanthracen-9-yl]-d-glucitol
14. (s)-1,8-dihydroxy-3-(hydroxymethyl)-10-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)anthracen-9(10h)-one
15. 5133-19-7
16. (10s)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-9,10-dihydroanthracen-9-one
17. Aloin(mixture Of A&b)
18. Aloin (mixture Of A And B)
19. 10-(1',5'-anhydroglucosyl)aloe-emodin-9-anthrone
20. Barbalin
21. Aloin, From Curacao Aloe, ~50%
22. Barbaloin-a
23. Nsc631263
24. Unii-648rw354s9
25. 10-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10h)-anthracenone
26. Nsc-407305
27. Aloin-a
28. 9(10h)-anthracenone, 10-.beta.-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10s)-
29. Barbaloin,(s)
30. Ncgc00183867-01
31. Aloin (barbaloin)
32. 8015-61-0
33. Einecs 215-808-0
34. Nsc 227189
35. Nsc 631263
36. Aloin(mixtureofaandb)
37. Aloin, Analytical Standard
38. Aloin A [mi]
39. Dsstox_rid_81262
40. Dsstox_rid_82951
41. Dsstox_gsid_45967
42. Dsstox_gsid_48755
43. Chembl2103763
44. Dtxsid0045967
45. Schembl14837254
46. Hy-n0123
47. Tox21_111495
48. Tox21_113216
49. S2375
50. Akos022168218
51. Zinc100018557
52. Ccg-268870
53. Cs-3707
54. Nsc 407305
55. Nsc 758464
56. (r)-10-beta-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)anthracen-9(10h)-one
57. 1,8-dihydroxy-10-(beta-d-glucopyranosyl)-3-(hydroxymethyl)-9(10h)-anthracenone
58. 9(10h)-anthracenone, 10-.beta.-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (s)-
59. Ncgc00183867-02
60. Cas-1415-73-2
61. Cas-8015-61-0
62. Ft-0772660
63. N2491
64. H10347
65. 415b732
66. A807778
67. Q413888
68. Aloin, From Aloe Barbadensis Miller Leaves, >=97%
69. Aloin, United States Pharmacopeia (usp) Reference Standard
70. 10-glucopyranosyl-1,8-dihydro-3-(hydroxymethyl)-9-anthracenone
71. 1,8-dihydroxy-10-(bet.-d-glucopyranosyl)-3-(hydroxymethyl)-9(10h)-anthracenone
72. 10-.beta.-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10h)-anthracenone-, 10(s)-
73. 10-beta-d-glucopyranosyl-1,8-dihydroxy-3-hydroxymethyl-9(10h)-anthrone,(r)-
74. 9(10h)-anthracenone, 10-beta-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10s)-
75. (10s)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]-10h-anthracen-9-one
76. (10s)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]-10h-anthracen-9-one;aloin
77. (10s)-10-.beta.-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10h)-anthracenone
78. (s)-1,8-dihydroxy-3-(hydroxymethyl)-10-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)anthracen-9(10h)-one(mixture Of A And B)
| Molecular Weight | 418.4 g/mol |
|---|---|
| Molecular Formula | C21H22O9 |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 418.12638228 g/mol |
| Monoisotopic Mass | 418.12638228 g/mol |
| Topological Polar Surface Area | 168 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 630 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Aloin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aloin, including repackagers and relabelers. The FDA regulates Aloin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aloin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aloin supplier is an individual or a company that provides Aloin active pharmaceutical ingredient (API) or Aloin finished formulations upon request. The Aloin suppliers may include Aloin API manufacturers, exporters, distributors and traders.
Aloin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aloin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aloin GMP manufacturer or Aloin GMP API supplier for your needs.
A Aloin CoA (Certificate of Analysis) is a formal document that attests to Aloin's compliance with Aloin specifications and serves as a tool for batch-level quality control.
Aloin CoA mostly includes findings from lab analyses of a specific batch. For each Aloin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aloin may be tested according to a variety of international standards, such as European Pharmacopoeia (Aloin EP), Aloin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aloin USP).
LOOKING FOR A SUPPLIER?
